tac 278 has been researched along with albuterol in 1 studies
| Studies (tac 278) | Trials (tac 278) | Recent Studies (post-2010) (tac 278) | Studies (albuterol) | Trials (albuterol) | Recent Studies (post-2010) (albuterol) |
|---|---|---|---|---|---|
| 11 | 0 | 0 | 10,108 | 3,059 | 2,058 |
| Protein | Taxonomy | tac 278 (IC50) | albuterol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 1.2618 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
1 other study(ies) available for tac 278 and albuterol
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |